-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
What’s Next?Artificial intelligence may help to classify colorectal polyps.
by Nancy Averett
-
Balancing Early-Stage Prostate Cancer Decisions
Choices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
-
When Cancer Is in the Family
You've inherited a genetic variant linked to cancer risk. Now what?
by Stephen Ornes
-
Survivor Profile
Strength in the PackWhile undergoing treatment for colon cancer, Trevor Maxwell started Man Up to Cancer, a support community for men.
by Jon Kelvey
-
Q&A
The Certainty of UncertaintyAfter a stage IV cancer diagnosis, Kate Bowler publishes a second memoir that explores the precarious nature of her own mortality.
by Marci A. Landsmann
-
Forward Look
CAR T Cells for Blood Cancer PatientsResearchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
-
Forward Look
There’s Time to Consider Fertility Preservation OptionsWomen with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.
by Kris Conner
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
Cancer Talk
Improving Communication for Deaf Cancer Patients
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.